Cargando…
Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe
OBJECTIVE: To evaluate the frequency with which relevant and accurate information about the benefits and related uncertainties of anticancer drugs are communicated to patients and clinicians in regulated information sources in Europe. DESIGN: Document content analysis. SETTING: European Medicines Ag...
Autores principales: | Davis, Courtney, Wagner, Anita K, Salcher-Konrad, Maximilian, Scowcroft, Henry, Mintzes, Barbara, Pokorny, Adrian M J, Lew, Jianhui, Naci, Huseyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053600/ https://www.ncbi.nlm.nih.gov/pubmed/36990506 http://dx.doi.org/10.1136/bmj-2022-073711 |
Ejemplares similares
-
Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States
por: SALCHER‐KONRAD, MAXIMILIAN, et al.
Publicado: (2020) -
Post‐Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004–2014
por: Cherla, Avi, et al.
Publicado: (2022) -
Twelve Years' Experience with Direct-to-Consumer Advertising of Prescription Drugs in Canada: A Cautionary Tale
por: Mintzes, Barbara, et al.
Publicado: (2009) -
Bicuspid aortic valve disease: systematic review and meta-analysis of surgical aortic valve repair
por: Salcher, Maximilian, et al.
Publicado: (2016) -
Avoidable costs of stenting for aortic coarctation in the United Kingdom: an economic model
por: Salcher, Maximilian, et al.
Publicado: (2017)